This post was originally published on this site
(Reuters) -A New Jersey appeals court on Tuesday threw out a $223.8 million verdict against Johnson & Johnson (NYSE:JNJ) that a jury had awarded to four plaintiffs who claimed they developed cancer from being exposed to asbestos in the company’s talc powder products.
The Superior Court of New Jersey, Appellate Division found that a lower court judge should not have allowed some of the scientific expert testimony the plaintiffs presented to jurors at trial.
J&J General Counsel Erik Haas said in a statement that the decision “resoundingly rejects … the ‘junk science’ advanced by purported ‘experts’ paid by the mass tort asbestos bar.” The company again said that its talc products are safe and do not contain asbestos.
A lawyer for the plaintiffs did not immediately respond to a request for comment.
The jury in the case had ordered the company to pay $37.2 million in compensatory damages and $750 million in punitive damages, though that amount was automatically reduced to $186.5 million under state law.
In reversing the verdict and ordering a new trial, a three-judge panel of the appeals court found that the trial court failed to fulfill its “gatekeeping role” of assessing whether the plaintiffs’ experts based their testimony on sound science.
In their opinion, the judges found that three experts had not explained the facts or methods they used to support their opinions that the plaintiffs got cancer from being exposed to asbestos in talc products.
J&J is separately suing one of those experts, Jacqueline Moline, over a study she co-authored in 2019. That study was not at issue in Tuesday’s decision.
Moline, who has testified for plaintiffs in more than 200 talc cancer cases, has argued that the lawsuit is an effort to “intimidate” scientific experts and prevent them from testifying against the company.
Tuesday’s ruling comes after the company in July failed for a second time to move tens of thousands of claims over talc into bankruptcy court, where it hoped to resolve them through a proposed $8.9 billion settlement.
